CompletedNCT03815825
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
PHASE2 · 332 planned enrolment
- Countries listed
- 9
- Registry update
- March 7, 2025
